The company said it was reviewing Mounjaro pricing with other governments and expected to make similar adjustments in certain markets from September 1
Weight-loss drugs
Latest in Weight-loss drugs
Obesity
Ozempic, Mounjaro: Celebrities embrace ‘vanity weight loss’ craze as experts warn of abuse, council natural remedies
While celebrities chase a fleeting concept of bodily perfection, the growing misuse of GLP-1 medications has revealed an ugly reality – that even the most promising new treatments are no match for society’s unhealthy obsession with thinness at all costs
Diabetes
‘Hostage economy’: Does Denmark risk over-reliance on Big Pharma as obesity drug boom fuels 4.5% GDP contribution?
Big Pharma’s profitable grip tightens as Danish weight loss drugs Wegovy and Saxenda, manufactured by Novo Nordisk, surge in popularity globally as people spend out of pocket
European Medicines Agency (EMA)
Popular UAE weight-loss drugs face investigation for life risk: Report
The safety assessment will focus on weight-loss drugs like Wegovy, Saxenda, and Ozempic, which help suppress appetite, the report said
